DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.409
EU - Europa 6.971
AS - Asia 5.848
SA - Sud America 713
AF - Africa 250
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 44
Totale 27.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.983
CN - Cina 2.242
SG - Singapore 1.712
RU - Federazione Russa 1.545
IT - Italia 1.530
DE - Germania 939
PL - Polonia 712
BR - Brasile 583
VN - Vietnam 534
HK - Hong Kong 496
GB - Regno Unito 382
UA - Ucraina 368
FR - Francia 356
CA - Canada 341
SE - Svezia 320
FI - Finlandia 312
ZA - Sudafrica 176
TR - Turchia 170
KR - Corea 151
IN - India 145
IE - Irlanda 115
JP - Giappone 85
CZ - Repubblica Ceca 82
NL - Olanda 62
BE - Belgio 60
MX - Messico 60
PK - Pakistan 51
AR - Argentina 50
AU - Australia 49
BD - Bangladesh 48
ES - Italia 48
EU - Europa 38
IQ - Iraq 35
IR - Iran 32
EG - Egitto 28
AT - Austria 23
EC - Ecuador 20
ID - Indonesia 18
SA - Arabia Saudita 17
UY - Uruguay 15
HR - Croazia 14
LT - Lituania 14
MY - Malesia 14
PT - Portogallo 13
PE - Perù 12
RO - Romania 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
BY - Bielorussia 9
CO - Colombia 9
HU - Ungheria 9
KE - Kenya 9
PH - Filippine 9
CL - Cile 8
GR - Grecia 8
UZ - Uzbekistan 7
AL - Albania 6
AZ - Azerbaigian 6
CH - Svizzera 6
KG - Kirghizistan 6
MA - Marocco 6
PS - Palestinian Territory 6
RS - Serbia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
LV - Lettonia 5
NP - Nepal 5
TN - Tunisia 5
JM - Giamaica 4
KH - Cambogia 4
QA - Qatar 4
SN - Senegal 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
GE - Georgia 3
LK - Sri Lanka 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
IS - Islanda 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
AO - Angola 1
Totale 27.265
Salva come PNG Salva come JPEG
Città #
Dallas 1.309
Ashburn 1.058
Fairfield 925
Singapore 925
Jacksonville 865
Woodbridge 819
San Jose 653
Chandler 602
Warsaw 579
Houston 522
Ann Arbor 517
Hong Kong 475
Wilmington 458
Boardman 425
Beijing 393
Seattle 371
Camerino 351
Cambridge 293
Nanjing 275
Toronto 233
Los Angeles 221
New York 214
Dearborn 203
Ho Chi Minh City 178
Helsinki 167
Johannesburg 159
The Dalles 154
Seoul 144
San Mateo 140
Tongling 140
Lawrence 130
Princeton 129
Istanbul 123
Lauterbourg 122
Hanoi 121
Dublin 116
Kraków 113
Munich 111
Columbus 108
Nanchang 103
Orem 100
Ogden 96
Moscow 95
Düsseldorf 93
London 93
Buffalo 88
Santa Clara 88
Milan 87
Shanghai 74
Shenyang 67
Tokyo 67
Guangzhou 64
Council Bluffs 60
São Paulo 60
Jiaxing 57
Kunming 57
Brno 56
Rome 54
Chicago 53
Brussels 52
Trieste 52
Frankfurt am Main 51
Lachine 50
Jinan 49
Tianjin 48
Turku 47
Chennai 46
San Diego 45
Manchester 41
Changsha 40
Hebei 39
Bremen 38
Centro 36
Philadelphia 34
Phoenix 33
Zhengzhou 32
Denver 30
Stockholm 30
Brooklyn 29
Dong Ket 29
Hangzhou 29
Montreal 29
Redondo Beach 29
Poplar 28
Da Nang 27
Mexico City 27
Redwood City 27
Wuhan 27
Ascoli Piceno 26
Nuremberg 25
Venezia 25
Ningbo 24
Amsterdam 23
Haiphong 23
Hefei 22
Perugia 22
Atlanta 21
Leawood 21
Mumbai 21
Sydney 20
Totale 17.700
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 628
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 615
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 615
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 551
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 522
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 354
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 343
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 330
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 327
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 326
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 307
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 303
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 302
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 294
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 293
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 290
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 284
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 267
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 264
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 262
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 253
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 250
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 246
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 241
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 240
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 238
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 238
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 234
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 226
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 225
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 218
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 216
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 213
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 209
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 209
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 209
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 207
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 206
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 203
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 202
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 202
Adenosine receptors as promising targets for the management of ocular diseases 202
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 199
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 198
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 198
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 195
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 195
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 195
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 194
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 193
4WD to Travel Inside the 5-HT1A Receptor World 193
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 192
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 190
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 189
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 188
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 187
Effects of imidazoline I2 receptor ligands on acute nociception in rats 187
New insights in Au-NHCs complexes as anticancer agents 187
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 186
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 186
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 185
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 183
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 183
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 183
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 179
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 178
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 178
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 176
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 175
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 174
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 173
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 172
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 172
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 170
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 168
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 167
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 164
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 163
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 162
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 161
Efficient Lewis Acid Systems for the A3 Coupling reaction 161
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 160
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 159
Imidazoline nucleus as a biologically versatile scaffold 156
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 155
Effects of allyphenyline on chronic alcohol intoxication model 154
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 152
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 150
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 149
Trekking through receptor chemistry 146
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 141
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 140
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 137
Aminopyrimidines as inhibitors of the Wnt signalling pathway 135
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 135
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 135
null 132
Synthesis, reactivity and biological studies of bioconjugated bis(pyrazolyl)acetate copper complexes 132
A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase 131
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 130
Totale 22.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.935
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021821 0 0 0 0 0 0 0 0 0 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.150 241 112 427 246 194 266 606 1.176 437 325 335 785
2025/20268.057 492 575 1.603 1.191 806 580 1.245 606 515 444 0 0
Totale 27.802